Comment
Author: Admin | 2025-04-28
With acute pulmonary emboli: a clinical review with cardiovascular focus. Expert Rev Cardiovasc Ther. 2012;10(2):235-250.8. Cleveland Clinic. Deep vein thrombosis. https://my.clevelandclinic.org/health/diseases/16911-deep-vein-thrombosis-dvt. Accessed March 26, 2018.9. National Blood Clot Alliance. What is pulmonary embolism (PE)? www.stoptheclot.org/diagnosis_symptoms/what_is_pe.htm. Accessed March 26, 2018.10. Belohlavek J, Dytrych V, Linhart A. Pulmonary embolism, part 1: epidemiology, risk factors, risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129-138.11. Corrigan D, Prucnal C, Kabrhel C. Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients. Clin Exp Emerg Med. 2016;3(3):117-125.12. Kearon C, Alk EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;142(6):1698-1704.13. Long B, Koyfman A. Current controversies in thrombolytic use in acute pulmonary embolism. J Emerg Med. 2016;51(1):37-44.14. Kearon C, Alk EA, Ornelas J, et al. Antithrombotic therapy for VTE disease. CHEST Guideline and Expert Panel Report. Chest 2016;149(2):315-352.15. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010;363(3):266-274.16. Condliffe R, Elliot CA, Hughes RJ, et al. Management dilemmas in acute pulmonary embolism. Thorax. 2014;69:174-180.17. Weinberg I. Appropriate use of inferior vena cava filters. American College of Cardiology. www.acc.org/latest-in-cardiology/articles/2016/10/31/09/28/appropriate-use-of-inferior-vena-cava-filters. Accessed April 1, 2018.18. Bikdeli B, Chatterjee S, Desai NR, et al. Inferior vena cava filters to prevent pulmonary embolism. J Am Coll Cardiol. 2017;70(13):1587-1597.19. Activase (alteplase) package insert. South San Francisco, CA: Genentech, Inc; 2018.20. Lovenox (enoxaparin sodium) package insert. Bridgewater, NJ: Sanofi-Aventis; 2017.21. Fragmin (dalteparin) package insert. Woodcliff Lake, NJ: Eisai Inc; 2007.22. Arixtra (fondaparinux) package insert. Rockford, IL: Mylan Institutional LLC; 2017.23. The Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349:1695-1702.24. Streiff MB, Agnelli G, Connors JM, et al. Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis. 2016;41:32-67.25. Heparin package insert. New York, NY: Pfizer Pharmacia & Upjohn Company; 2006.26. Coumadin package insert. Princeton, NJ: Bristol-Myers Squibb Pharma Company; 2017.27. The EINSTEIN-PE Investigators. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287-1297.28. Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369(9):799-808.29. Pradaxa (dabigatran) package insert. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2018.30. Savaysa (edoxaban) package insert. Basking Ridge, NJ: Daiichi Sankyo Co., LTD; 2017.31. Xarelto (rivaroxiban) package insert. Titusville, NJ: Janssen Pharmaceuticals, Inc.; 2011.32. Eliquis (apixaban) package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2017.33. Agnelli G, Buller HR, Cohen A, et al. Apixaban for extended treatment of venous thromboembolism. N Engl J Med. 2013;368(8):699-708.34. Weitz JI, Lensing AWA, Prins MH, et al. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med. 2017;376(13):1211-1222.35. Simes J, Becattini C, Agnelli G, et al. Aspirin for the prevention of recurrent venous thromboembolism (The INSPIRE Collaboration). Circulation. 2014;130:1062-1071.36. Dobesh PP, Trujillo TC, Finks SW. Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism.
Add Comment